1999
DOI: 10.1097/00008390-199906000-00009
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value of tumour vascularity in primary melanoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2000
2000
2011
2011

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(29 citation statements)
references
References 0 publications
0
29
0
Order By: Relevance
“…More surprisingly, a similar immunohistochemical analysis of primary cutaneous melanomas samples taken from 84 patients showed that the only independent variable associated with disease-free survival was tumor thickness (Breslow classification). The only variable associated with overall survival was depth of tumor infiltration (Clark classification), whereas high levels of vascularity were actually correlated with survival (Ilmonen et al, 1999).…”
Section: Tumor Angiogenesis In Melanomamentioning
confidence: 97%
“…More surprisingly, a similar immunohistochemical analysis of primary cutaneous melanomas samples taken from 84 patients showed that the only independent variable associated with disease-free survival was tumor thickness (Breslow classification). The only variable associated with overall survival was depth of tumor infiltration (Clark classification), whereas high levels of vascularity were actually correlated with survival (Ilmonen et al, 1999).…”
Section: Tumor Angiogenesis In Melanomamentioning
confidence: 97%
“…On the other hand, some investigators 73,74 report an association between high "vascularity" and outcome in cutaneous melanoma while Ilmonen et al 75,76 recently reported that high vascularity was associated with a favorable outcome.…”
Section: Counting Microvessels and Vasculogenic Mimicrymentioning
confidence: 99%
“…The unique topology of VM distribution is consistent with the notion that specific molecular and cellular modifications occur, which facilitate tumor invasion and growth. Therefore, VM is a poor prognosis indicator in patients with sarcomas and melanomas (21)(22)(23).…”
Section: 08 --------------------------------------------------------mentioning
confidence: 99%